E. Otero

发表

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

S. Tomé, J. Castroagudín, E. Molina, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Serum levels of cytokeratin‐18 (tissue polypeptide‐specific antigen) in liver diseases

A. González-Quintela, N. Mallo, S. Tomé, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Access to new direct‐acting antiviral agents against HCV infection: A view from Spain

S. Tomé, E. Otero, 2015, Clinical liver disease.

Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease.

I. Abdulkader, J. Forteza, F. Gudé, 2002, Journal of hepatology.

Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach

C. Cadarso-Suárez, F. Gudé, A. González-Quintela, 2021, Scientific Reports.

Rate and Predictors of Treatment Failure to All-Oral HCV Regimens outside Clinical Trials

V. Cuervas-Mons, V. Soriano, A. Aguilera, 2016, Antiviral therapy.

Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.

S. Tomé, J. Castroagudín, E. Molina, 2010, Transplantation proceedings.

Clinical and capillaroscopic findings in patients with liver disease and proximal apparent leukonychia (Terry nails and its variants)

A. González-Quintela, S. Tomé, E. Otero, 2021, Medicine.

Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy.

A. González-Quintela, F. Segade, S. Tomé, 2002, Transplantation proceedings.

Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease.

I. Abdulkader, A. González-Quintela, C. Mella, 2004, Alcoholism, clinical and experimental research.

Truly de novo Hepatitis B After Liver Transplantation

A. González-Quintela, S. Tomé, E. Varó, 2004, American Journal of Gastroenterology.

Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co‐infection

A. Antela, E. Molina, E. Varó, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Chordoid meningioma in a patient with lymphangioleiomyomatosis

I. Abdulkader, A. González-Quintela, E. Otero, 2011, Journal of Neuro-Oncology.

Gastrointestinal complications in liver transplant recipients: MITOS study.

I. Bilbao, J. Herrero, M. Rodríguez, 2007, Transplantation proceedings.

Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.

F. Segade, S. Tomé, J. Castroagudín, 2005, Transplantation proceedings.

Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.

A. González-Quintela, S. Tomé, J. Torre, 2003, Hepato-gastroenterology.

Epithelioid hemangioendothelioma in the posterior mediastinum.

A. González-Quintela, M. Domínguez, J. Campos, 2007, European journal of internal medicine.

Time-Course Changes of Serum Keratin Concentrations after Liver Transplantation: Contrasting Results of Keratin-18 and Keratin-19 Fragments

I. Abdulkader, A. González-Quintela, S. Tomé, 2020, Case Reports in Hepatology.

Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C

I. Abdulkader, A. González-Quintela, S. Tomé, 2010, Clinical chemistry and laboratory medicine.

Keratin‐18 as a marker of steatohepatitis

A. González-Quintela, S. Lojo, E. Otero, 2007, Hepatology.

Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.

I. Abdulkader, A. González-Quintela, S. Tomé, 2006, Alcohol.

Quality of Life and Employment after Liver Transplantation

M. Lucey, S. Tomé, E. Otero, 2021, Liver Transplantation.

Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil

J. Herrero, V. Cuervas-Mons, D. D’Avola, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.

I. Abdulkader, S. Tomé, J. Castroagudín, 2005, Transplantation proceedings.

Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus.

A. González-Quintela, J. Castroagudín, E. Varó, 2002, Transplantation proceedings.

Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab.

S. Tomé, J. Castroagudín, E. Varó, 2002, Transplantation proceedings.

Abnormalities in liver enzyme levels during Salmonella enteritidis enterocolitis.

A. González-Quintela, S. Tomé, J. Torre, 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Brief report Epithelioid hemangioendothelioma in the posterior mediastinum

A. González-Quintela, M. Domínguez, E. Otero, 2007 .

Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence.

M. Rodríguez, S. Tomé, J. Castroagudín, 2009, Transplantation proceedings.

Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.

F. Segade, S. Tomé, J. Castroagudín, 2008, Transplantation proceedings.